NCT03555617View on ClinicalTrials.gov

Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 13, 2018

Primary Completion Date

July 15, 2018

Study Completion Date

July 15, 2018

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

TD-1473

oral capsule/tablet, QD

DRUG

Itraconazole

oral solution, QD

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY